Ser9Gly dopamine D3 receptor polymorphism and spontaneous dyskinesia in never-medicated schizophrenic patients.
about
Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophreniaApplications of pharmacogenetics in psychiatry: personalisation of treatment.Recent advances in the genetics of schizophrenia.Receptor pharmacogenetics: relevance to CNS syndromesExtrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.No association between dopamine D3 receptor gene Ser9Gly polymorphism (rs6280) and risk of schizophrenia: an updated meta-analysis.
P2860
Ser9Gly dopamine D3 receptor polymorphism and spontaneous dyskinesia in never-medicated schizophrenic patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Ser9Gly dopamine D3 receptor p ...... icated schizophrenic patients.
@en
Ser9Gly dopamine D3 receptor p ...... icated schizophrenic patients.
@nl
type
label
Ser9Gly dopamine D3 receptor p ...... icated schizophrenic patients.
@en
Ser9Gly dopamine D3 receptor p ...... icated schizophrenic patients.
@nl
prefLabel
Ser9Gly dopamine D3 receptor p ...... icated schizophrenic patients.
@en
Ser9Gly dopamine D3 receptor p ...... icated schizophrenic patients.
@nl
P2093
P2860
P356
P1433
P1476
Ser9Gly dopamine D3 receptor p ...... icated schizophrenic patients.
@en
P2093
P2860
P2888
P356
10.1038/SJ.MP.4000822
P407
P577
2001-01-01T00:00:00Z